glutathione content in borrelia burgdorferi infection modifies protein saliva of Ixodes scapularis nymphs | BMC Genomics Lyme borreliosis | Nature Reviews

Retevmo is specifically indicated for advanced or metastatic medullary thyroid cancer with a RET mutation, advanced or metastatic thyroid cancer with a RET gene fusion untreatable with radioactive iodine therapy, and locally advanced or metastatic solid tumors with a RET gene fusion that have progressed after prior systemic treatment or have no treatment options, according to the publication

of n = 50 cells from three independent experiments per strain

REDUCES HYPERPIGMENTATION Supports the reduction of dark spots, tanning, and uneven patches for a clearer, more balanced complexion

These combined actions underscore their therapeutic potential for NAFLD (89, 90)